Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells

This publication has 73 references indexed in Scilit:

• Will newer tyrosine kinase inhibitors have an impact in AML?
  Best Practice & Research Clinical Haematology, 2010
• Phosphoproteomics in cancer
  Molecular Oncology, 2010
• Proteomic and Genetic Approaches Identify Syk as an AML Target
  Cancer Cell, 2009
• Regulatory Autophosphorylation Sites on Protein Kinase C-δ at Threonine-141 and Threonine-295
  Biochemistry, 2009
• Is the focus moving toward a combination of targeted drugs?
  Best Practice & Research Clinical Haematology, 2008
• MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
  Nature Biotechnology, 2008
• Integration of biological networks and gene expression data using Cytoscape
  Nature Protocols, 2007
• Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  Nature Biotechnology, 2007
• Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments
  FEBS Letters, 2004
• Site-Specific Incorporation of a Phosphotyrosine Mimetic Reveals a Role for Tyrosine Phosphorylation of SHP-2 in Cell Signaling
  Molecular Cell, 2001